Clinical Trial Detail

NCT ID NCT01846624
Title Decitabine and Midostaurin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bruno C. Medeiros
Indications

acute myeloid leukemia

Therapies

Decitabine + Midostaurin

Age Groups: senior adult

No variant requirements are available.